600276.SS
Price:
$60.85
Market Cap:
$388.16B
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
Industry
Drug Manufacturers - General
IPO Date
2000-10-18
Stock Exchange
SHH
Ticker
600276.SS
According to Jiangsu Hengrui Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 14.19%. This represents a change of 295.54% compared to the average of 3.59% of the last 4 quarters.
The mean historical ROE of Jiangsu Hengrui Medicine Co., Ltd. over the last ten years is 17.44%. The current 14.19% ROE has changed -18.61% with respect to the historical average. Over the past ten years (40 quarters), 600276.SS's ROE was at its highest in in the December 2020 quarter at 6.79%. The ROE was at its lowest in in the December 2021 quarter at 0.92%.
Average
17.44%
Median
20.68%
Minimum
10.33%
Maximum
21.87%
Discovering the peaks and valleys of Jiangsu Hengrui Medicine Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.93%
Maximum Annual ROE = 21.87%
Minimum Annual Increase = -37.61%
Minimum Annual ROE = 10.33%
| Year | ROE | Change |
|---|---|---|
| 2024 | 13.92% | 30.93% |
| 2023 | 10.63% | 2.95% |
| 2022 | 10.33% | -20.20% |
| 2021 | 12.94% | -37.61% |
| 2020 | 20.75% | -3.53% |
| 2019 | 21.51% | 4.35% |
| 2018 | 20.61% | -1.54% |
| 2017 | 20.93% | 0.15% |
| 2016 | 20.90% | -4.42% |
| 2015 | 21.87% | 14.47% |
The current ROE of Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.63%
5-year avg
13.71%
10-year avg
17.44%
Jiangsu Hengrui Medicine Co., Ltd.’s ROE is less than Zhangzhou Pientzehuang Pharmaceutical., Ltd (16.51%), less than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (22.52%), less than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (15.80%), less than Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (2.66%), less than Sichuan Kelun Pharmaceutical Co., Ltd. (7.17%), less than Hunan Jingfeng Pharmaceutical Co.,Ltd. (262.84%), less than WuXi AppTec Co., Ltd. (23.34%), less than Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (55.46%), less than Yifan Pharmaceutical Co., Ltd. (4.68%), less than Zhejiang Zhenyuan Share Co., Ltd. (2.36%),
| Company | ROE | Market cap |
|---|---|---|
| 16.51% | $104.71B | |
| 22.52% | $240.03B | |
| 15.80% | $15.24B | |
| 2.66% | $3.07B | |
| 7.17% | $50.64B | |
| 262.84% | $6.75B | |
| 23.34% | $228.70B | |
| 55.46% | $2.13B | |
| 4.68% | $14.60B | |
| 2.36% | $3.21B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Hengrui Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jiangsu Hengrui Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Jiangsu Hengrui Medicine Co., Ltd.'s ROE?
How is the ROE calculated for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the highest ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the 3-year average ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
What is the 5-year average ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?
How does the current ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) compare to its historical average?